BONK, INC. BNKK
Inc. (NASDAQ: BNKK) was formerly known as Safety Shot, Inc., and prior to that, Jupiter Wellness, Inc.
August 2023 Jupiter Wellness, Inc. acquired certain assets of GBB Drink Lab Inc which included the blood alcohol reduction drink Sure
Shot (the "Sure Shot Dietary Supplement"), an over-the-counter drink that can lower blood alcohol content to allow recovery
from the effects of alcohol by supporting its metabolism, relying on 28 active ingredients, all falling under the FDA's Generally
Last close
1.08
2026-10-23
Market cap
$8.7M
2026-06-30 share count
52-week range
0.90 - 9.03
Valuation FY2025 figures against the last close
P/S4.1x
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS-17.02
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.1M | $702.0K | $202.7K | $120.6K | $2.9M | $1.1M | $6.5K | — |
| Cost of revenue | $2.7M | $3.1M | $277.1K | $325.2K | $2.3M | $624.6K | $18.0K | — |
| Gross profit | $1.2M | -$2.4M | -$74.5K | -$204.5K | $535.5K | $441.1K | $11.6K | — |
| R&D | $24.2K | $100.6K | $100.6K | $1.6M | $1.1M | $308.4K | — | — |
| SG&A | $35.7M | $39.6M | $12.5M | $11.6M | $17.3M | $5.6M | $908.7K | — |
| Total operating expenses | — | $39.6M | $12.5M | $14.1M | $27.6M | $6.6M | — | — |
| Interest expense | — | — | — | — | $1.7M | $116.8K | $6.6K | — |
| Net income | -$68.2M | -$49.4M | -$15.1M | -$15.2M | -$28.1M | -$6.3M | -$925.5K | — |
| EPS, basic | -17.02 | -31.77 | -0.49 | -0.69 | -1.69 | -0.86 | -0.15 | — |
| EPS, diluted | -17.02 | -31.77 | -0.49 | -0.69 | -1.69 | -0.86 | — | — |
| Shares, diluted (wtd. avg.) | 4.0M | 1.6M | 30.9M | 22.1M | 16.6M | 7.3M | 6.3M | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | — | — | — | — | $4.3M | $531.0K | $161.3K |
| Short-term investments | $54.7K | $54.7K | $843.0K | $2.9M | $2.9M | — | — | — |
| Receivables | $90.1K | $283.6K | $5.6K | $26.4K | $695.3K | — | — | — |
| Inventory | $949.3K | $233.5K | $795.8K | $151.2K | $304.3K | $225.9K | $135.5K | — |
| Total current assets | $6.0M | $2.6M | $7.7M | $6.8M | $16.3M | $5.0M | $745.8K | — |
| Property, plant and equipment | $66.2K | $94.0K | $28.3K | $52.5K | $109.1K | $35.6K | — | — |
| Goodwill | $14.1M | $0 | $0 | $0 | $941.9K | $941.9K | — | — |
| Other intangibles | $1.3M | $4.4M | $4.5M | $291.5K | $364.4K | $559.8K | — | — |
| Total assets | $41.0M | $7.3M | $12.7M | $8.7M | $18.9M | $6.5M | $745.8K | — |
| Accounts payable | $2.5M | $2.2M | $1.5M | $1.5M | $1.2M | $688.8K | $10.7K | — |
| Total current liabilities | $6.0M | $9.4M | $3.6M | $4.5M | $1.6M | $2.1M | $336.4K | — |
| Total liabilities | $6.0M | $9.5M | $3.9M | $5.0M | $2.3M | $2.1M | $366.6K | — |
| Retained earnings | -$183.5M | -$115.1M | -$65.7M | -$50.6M | -$35.4M | -$7.3M | -$985.2K | — |
| Total equity | $35.0M | -$2.2M | $8.8M | $3.7M | $16.6M | $4.4M | $379.2K | $184.3K |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$25.3M | -$18.1M | -$10.7M | -$6.4M | -$7.6M | -$2.7M | -$692.7K | — |
| Depreciation and amortisation | $654.4K | $428.8K | $214.1K | $20.6K | $187.9K | $161.4K | — | — |
| Stock-based compensation | $9.8M | $5.1M | $1.1M | $3.2M | $9.4M | $2.4M | $357.9K | — |
| Capital expenditure | — | $87.2K | $106.2K | $15.0K | $88.3K | $44.0K | — | — |
| Investing cash flow | $5.8M | -$4.9K | -$330.0K | -$2.5M | -$13.1M | -$246.0K | — | — |
| Financing cash flow | $21.4M | $15.6M | $12.8M | -$904.2K | $28.2M | $6.7M | $1.1M | — |
| Buybacks | — | — | — | $2.9M | — | — | — | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001493152-26-014015.
Plot the figures US dollars
Income statement
Revenue
Cost of revenue
Gross profit
R&D
SG&A
Total operating expenses
Operating income
Interest expense
Pre-tax income
Income tax
Net income
EPS, basic
EPS, diluted
Shares, diluted (wtd. avg.)
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $6.5K | $1.1M | $2.9M | $120.6K | $202.7K | $702.0K | $2.1M |
| Gross profit | — | $11.6K | $441.1K | $535.5K | -$204.5K | -$74.5K | -$2.4M | $1.2M |
| Net income | — | -$925.5K | -$6.3M | -$28.1M | -$15.2M | -$15.1M | -$49.4M | -$68.2M |
Recent filings and events
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
- Officer or director change Item 5.02
- Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
- Officer or director change Item 5.02
- Officer or director change Item 5.02
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Charter or fiscal year changed A change to the company's governing documents, or to when its year ends. Item 5.03
- Regulation FD disclosure Item 7.01
- Charter or fiscal year changed Item 5.03
- Delisting notice The exchange has told the company it no longer meets the rules for staying listed - usually price, market cap, or filings that are late. Item 3.01
- Officer or director change Item 5.02
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 2844
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| CL | COLGATE PALMOLIVE CO | $74.97B | 35.8x | 1.4% |
| EL | ESTEE LAUDER COMPANIES INC | $39.37B | 217.3x | 5.0% |
| KVUE | Kenvue Inc. | $37.59B | 25.8x | -2.1% |
| ELF | e.l.f. Beauty, Inc. | $6.74B | 259.6x | 24.6% |
| IPAR | INTERPARFUMS INC | $3.69B | 22.0x | 2.5% |
| COTY | COTY INC. | $2.84B | — | -1.5% |
| EPC | EDGEWELL PERSONAL CARE Co | $1.29B | 52.9x | -1.3% |
| WALD | Waldencast plc | $100.3M | — | -0.7% |